Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Larson, G. P.
Right arrow Articles by Krontiris, T. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Larson, G. P.
Right arrow Articles by Krontiris, T. G.
[Cancer Research 65, 805-814, February 1, 2005]
© 2005 American Association for Cancer Research


Molecular Biology, Pathobiology and Genetics

Genetic Linkage of Prostate Cancer Risk to the Chromosome 3 Region Bearing FHIT

Garry P. Larson1, Yan Ding1, Li S-C. Cheng2, Cathryn Lundberg1, Virgil Gagalang1, Guillermo Rivas1, Louis Geller1, Jeffrey Weitzel1,3, Deborah MacDonald3, John Archambeau4, Jerry Slater4, Donna Neuberg5, Mary B. Daly6, Irene Angel6, Al B. Benson, III7, Kimberly Smith8, John M. Kirkwood9, Peter J. O'Dwyer10, Barbara Raskay10, Rebecca Sutphen11, Rosalind Drew11, James A. Stewart12, Jae Werndli12, David Johnson13, John C. Ruckdeschel14, Robert C. Elston15 and Theodore G. Krontiris1

1 Divisions of Molecular Medicine and 2 Information Sciences, Beckman Research Institute and 3 Department of Cancer Genetics, City of Hope National Medical Center, Duarte, California; 4 Department of Radiation Medicine, Loma Linda University Medical Center, Loma Linda, California; 5 Division of Biostatistics, Dana-Farber Cancer Institute, Harvard Medical School and Department of Biostatistics, Harvard School of Public Health, Boston, Massachusetts; 6 Department of Population Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania; 7 Department of Medicine, Division of Hematology/Oncology and 8 Clinical Research Office, Robert J. Lurie Comprehensive Cancer Center, Northwestern University School of Medicine, Chicago, Illinois; 9 Department of Medicine, Division of Hematology/Oncology, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania; 10 Department of Medicine, Hematology-Oncology Division, University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania; 11 Interdisciplinary Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, Florida; 12 University of Wisconsin Comprehensive Cancer Center and University of Wisconsin School of Medicine, Madison, Wisconsin; 13 Division of Hematology & Oncology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee; 14 Barbara Ann Karmanos Cancer Institute, Detroit, Michigan; and 15 Department of Epidemiology and Biostatistics, Case Western Reserve University, Metro Health Medical Center, Cleveland, Ohio

Requests for reprints: Theodore G. Krontiris, Division of Molecular Medicine, Beckman Research Institute, City of Hope National Medical Center, 1500 East Duarte Road, Duarte, CA 91010-3000. Phone: 626-359-8111 ext. 64297; Fax: 626-930-5394; E-mail: tkrontir{at}.coh.org.

We conducted linkage analysis of 80 candidate genes in 201 brother pairs affected with prostatic adenocarcinoma. Markers representing two adjacent candidate genes on chromosome 3p, CDC25A and FHIT, showed suggestive evidence for linkage with single-point identity-by-descent allele-sharing statistics. Fine-structure multipoint linkage analysis yielded a maximum LOD score of 3.17 (P = 0.00007) at D3S1234 within FHIT intron 5. For a subgroup of 38 families in which three or more affected brothers were reported, the LOD score was 3.83 (P = 0.00001). Further analysis reported herein suggested a recessive mode of inheritance. Association testing of 16 single nucleotide polymorphisms (SNP) spanning a 381-kb interval surrounding D3S1234 in 202 cases of European descent with 143 matched, unrelated controls revealed significant evidence for association between case status and the A allele of single nucleotide polymorphism rs760317, located within intron 5 of FHIT (Pearson's {chi}2 = 8.54, df = 1, P = 0.0035). Our results strongly suggest involvement of germline variations of FHIT in prostate cancer risk.




This article has been cited by other articles:


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. M. Levin, A. M. Ray, K. A. Zuhlke, J. A. Douglas, and K. A. Cooney
Association between Germline Variation in the FHIT Gene and Prostate Cancer in Caucasians and African Americans
Cancer Epidemiol. Biomarkers Prev., June 1, 2007; 16(6): 1294 - 1297.
[Abstract] [Full Text] [PDF]


Home page
NeurologyHome page
H. Deng, W. D. Le, Y. Guo, M. S. Huang, W. J. Xie, and J. Jankovic
Extended study of A265G variant of HS1BP3 in essential tremor and Parkinson disease
Neurology, August 23, 2005; 65(4): 651 - 652.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2005 by the American Association for Cancer Research.